Cargando…

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects

Inert microspheres, labeled with several radionuclides, have been developed during the last two decades for the intra-arterial treatment of liver tumors, generally called Selective Intrahepatic radiotherapy (SIRT). The aim is to embolize microspheres into the hepatic capillaries, accessible through...

Descripción completa

Detalles Bibliográficos
Autores principales:	d’Abadie, Philippe, Hesse, Michel, Louppe, Amandine, Lhommel, Renaud, Walrand, Stephan, Jamar, Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271370/ https://www.ncbi.nlm.nih.gov/pubmed/34209590 http://dx.doi.org/10.3390/molecules26133966

Ejemplares similares

Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters
por: Hesse, Michel, et al.
Publicado: (2021)

Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria
por: d’Abadie, Philippe, et al.
Publicado: (2022)

TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy
por: Walrand, Stephan, et al.
Publicado: (2021)

A Theranostic Approach in SIRT: Value of Pre-Therapy Imaging in Treatment Planning
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Optimal Design of Anger Camera for Bremsstrahlung Imaging: Monte Carlo Evaluation
por: Walrand, Stephan, et al.
Publicado: (2014)

Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom
por: Walrand, Stephan, et al.
Publicado: (2011)

Statistical and radiobiological analysis of the so-called thyroid stunning
por: Walrand, Stephan, et al.
Publicado: (2015)

Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database
por: Roelants, Véronique, et al.
Publicado: (2012)

Diagnostic Superiority of Dual-Time Point [(18)F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors
por: d’Abadie, Philippe, et al.
Publicado: (2023)

Vertebral uptake of (99m)Tc-macroaggregated albumin during lung perfusion scanning
por: D’Abadie, Philippe, et al.
Publicado: (2019)

Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy
por: Walrand, Stephan, et al.
Publicado: (2012)

Successful treatment with yttrium-90 microspheres in a metastatic breast cancer patient and sclerosing cholangitis
por: Louvet, Aurélie, et al.
Publicado: (2021)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
por: Walrand, Stephan, et al.
Publicado: (2021)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

EANM dosimetry committee series on standard operational procedures: a unified methodology for (99m)Tc-MAA pre- and (90)Y peri-therapy dosimetry in liver radioembolization with (90)Y microspheres
por: Chiesa, Carlo, et al.
Publicado: (2021)

Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Facile Preparation of Samarium Carbonate-Polymethacrylate Microspheres as a Neutron-Activatable Radioembolic Agent for Hepatic Radioembolization
por: Wong, Yin How, et al.
Publicado: (2023)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with (90)Y-Microspheres: A Systematic Review
por: Birgin, Emrullah, et al.
Publicado: (2020)

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
por: Alonso, JC, et al.
Publicado: (2023)

Significant artefactual noise in (90)Y TOF-PET imaging of low specific activity phantoms arises despite increased acquisition time
por: Hesse, Michel, et al.
Publicado: (2019)

Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
por: Drescher, Robert, et al.
Publicado: (2023)

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
por: Cappelli, Alberta, et al.
Publicado: (2014)

Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization
por: Elschot, Mattijs, et al.
Publicado: (2013)

Radioembolization with (90)Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy
por: Braat, A. J. A. T., et al.
Publicado: (2019)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2022)

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with (90)Y microspheres
por: Yim, Sun Young, et al.
Publicado: (2014)

Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma
por: Chan, Hui-Wen, et al.
Publicado: (2022)

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)

Radioembolization treatment for liver metastases
por: Kiszkaą, Joanna, et al.
Publicado: (2017)

Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
por: Henry, E. Courtney, et al.
Publicado: (2023)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
por: Ghosh, Abheek, et al.
Publicado: (2022)

Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review
por: Alonso, J. C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vqupca8jp06efa0qh5ca9j8pph